CB1 + CB2 receptor (inverse agonist): Most evidence suggests that CBD oil has a low affinity for CB1 and CB2 receptor sites as an inverse agonist. In other words, it binds to the CB1 and CB2 receptors but exerts the pharmacologically opposite effect to an agonist. This differs from a CB1/CB2 antagonist which solely binds to these receptors and blocks stimulation from endocannabinoids.
Although the science is still unclear on the subject, cannabis oil is being considered as a natural cancer treatment as well as cancer preventer option because it may decrease the size of tumors and alleviate nausea, pain, lack of appetite and weakness. The U.S. Food and Drug Administration has not approved alternative cannabis oil cancer treatment or use of cannabis oil for any other medical condition, but research shows that it has some anti-cancer properties.
Whether the claim of 10-fold bioavailability of nano-engineered CBD can be scientifically verified isn’t known, however, preliminary testing from the company suggests that 10 mg of their product is equivalent to 100 mg of others. Assuming the nano-engineering is effectively increasing bioavailability by 10-fold, each BioCBD+ capsule I’ve taken (with 10 mg CBD) is delivering the equivalent of 100 mg standard CBD.
CBD has a broad pharmacological profile, including interactions with several receptors known to regulate fear and anxiety-related behaviors, specifically the cannabinoid type 1 receptor (CB1R), the serotonin 5-HT1A receptor, and the transient receptor potential (TRP) vanilloid type 1 (TRPV1) receptor [11, 12, 19, 21]. In addition, CBD may also regulate, directly or indirectly, the peroxisome proliferator-activated receptor-γ, the orphan G-protein-coupled receptor 55, the equilibrative nucleoside transporter, the adenosine transporter, additional TRP channels, and glycine receptors [11, 12, 19, 21]. In the current review of primary studies, the following receptor-specific actions were found to have been investigated as potential mediators of CBD’s anxiolytic action: CB1R, TRPV1 receptors, and 5-HT1A receptors. Pharmacology relevant to these actions is detailed below.
CBD interacts mostly with CB1 receptors which are spread throughout the entire body, but they’re found in the highest concentrations in the immune and nervous systems. The interaction between CBD and endocannabinoid receptors, proteins, and other chemicals in the brain, triggers changes in the activity of hormones, and neurotransmitters throughout the brain and the body.
Additionally, CBD oil can benefit people with other medical conditions. CBD oil may be prescribed for patients with Lennox-Gastaut syndrome or Dravet syndrome, two rare forms of severe epilepsy; the medication Epidolex, a CBD oil oral solution, is typically prescribed in these instances. Many people with depression, anxiety, post-traumatic stress disorder, and other mental health disorders have also found that CBD oil has a calming, therapeutic effect when they experience symptoms. Most medical experts agree that marijuana is not particularly beneficial for these individuals, as the THC can increase the symptoms of these disorders, making CBD oil a good alternative option.
Selective Serotonin Reuptake Inhibitors (SSRIs) like Celexa, Lexapro, and Zoloft, are primarily prescribed to treat depression. They work by preventing serotonin from being absorbed by the brain, increasing its availability. SSRIs are popular antidepressants that can be used long-term and are commonly prescribed to those who suffer from anxiety as well.
In terms of eye health, cannabis and cannabis essential oil have been linked to a reduction in glaucoma and a prevention of macular degeneration, according to a report published by Dr. John Merritt, Department of Ophthalmology School of Medicine, University of North Carolina. Eye health is one of the major reasons why people turn to cannabis essential oil as they age.
A review published in 2017 in the journal Frontiers in Pharmacology described how CBD may work to protect the hippocampus — the part of the brain responsible for several important functions, such as learning, memory and navigation — during times of stress, and may also help prevent brain-cell destruction that results from schizophrenia. Another 2017 review published in the journal Annals of Palliative Medicine summarized a handful of studies that suggest cannabis oils containing THC or CBD, or both, may help with chronic pain management, but the mechanism is unclear.
Affiliate Disclosure: There are links on this site that can be defined as affiliate links. This means that I may receive a small commission (at no cost to you) if you purchase something when clicking on the links that take you through to a different website. By clicking on the links, you are in no way obligated to buy.
Medical Disclaimer: Statements in any video or written content on this site have not been evaluated by the FDA. If you are pregnant, nursing, taking medications, or have a medical condition, consult your physician before using this product. Representations regarding the efficacy and safety of CBD oil have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. The material on this site is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any supplement program.
Copyright © thejoyfullotus.com